NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,855 | -53.5% | 46,970 | 0.0% | 0.05% | -58.1% |
| Q2 2023 | $87,834 | -49.5% | 46,970 | -95.0% | 0.12% | +6.9% |
| Q1 2023 | $173,791 | -2.7% | 939,412 | 0.0% | 0.12% | +18.4% |
| Q4 2022 | $178,676 | -51.8% | 939,412 | 0.0% | 0.10% | -52.7% |
| Q3 2022 | $371,000 | -62.4% | 939,412 | 0.0% | 0.21% | -58.3% |
| Q2 2022 | $986,000 | -44.2% | 939,412 | 0.0% | 0.50% | -32.9% |
| Q1 2022 | $1,766,000 | -33.1% | 939,412 | 0.0% | 0.74% | -30.0% |
| Q4 2021 | $2,640,000 | – | 939,412 | – | 1.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CARNEGIE MELLON UNIVERSITY | 939,412 | $371,000 | 0.21% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 470,524 | $186,000 | 0.20% |
| CM Management, LLC | 450,000 | $178,000 | 0.20% |
| Decheng Capital Management III (Cayman), LLC | 1,000,000 | $395,000 | 0.14% |
| AIGH Capital Management LLC | 872,023 | $345,000 | 0.11% |
| Greenlight Capital | 2,727,027 | $1,077,000 | 0.08% |
| Worth Venture Partners, LLC | 212,035 | $84,000 | 0.05% |
| PERKINS CAPITAL MANAGEMENT INC | 98,000 | $39,000 | 0.04% |
| Sio Capital Management, LLC | 259,441 | $102,000 | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $123,000 | 0.00% |